Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Whole Exome Sequencing of Chronic Myeloid Leukemia Patients



Sabri S1 ; Keyhani M2 ; Akbari MT1
Authors

Source: Iranian Journal of Public Health Published:2016

Abstract

Background: Previous studies have shown that leukemogenic chromosomal translocations, including fusions be-tween Break point Cluster Region (BCR) and Abelson (ABL) are present in the peripheral blood of healthy individu-als. The aim of this study was to gain insights into the genetic alterations other than BCR-Abl translocation in molecu-lar level, which cause chronic myeloid leukemia (CML). Methods: We performed whole-exome sequencing on four cases representative of BCR-ABL positive CML in chron-ic phase of the disease. Results: We did not identify any pathogenic mutation in all known genes involved in CML or other cancers in our subjects. Nevertheless, we identified polymorphisms in related genes. Conclusion: It is the first report of exome sequencing in Philadelphia chromosome positive CML patients. We did not identify any pathogenic mutation in known cancer genes in our patients who can be due to CML pathogenesis or technical limitations. © 2016, Iranian Journal of Public Health. All rights reserved.
Other Related Docs
5. Association of G15631t, Cyp2b6 Gene Polymorphism With Susceptibility to Acute Myeloid Leukemia, Journal of Zanjan University of Medical Sciences and Health Services (2016)
8. Genetic, Hematologic and Psychological Aspects of Leukemia, Cancer Genetics and Psychotherapy (2017)
9. Investigation of Cebpa and Cebpa-As Genes Expression in Acute Myeloid Leukemia, Reports of Biochemistry and Molecular Biology (2019)
12. Cdkn2b Methylation Correlates With Survival in Aml Patients, Iranian Journal of Pharmaceutical Research (2017)
13. Gene Panel Testing in Hereditary Breast Cancer, Archives of Iranian Medicine (2020)
16. A Single Center Study of Prescribing and Treatment Outcomes of Patients With Chronic Myeloid Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2020)